Discontinued Operations - Summary of Discontinued Operations in Consolidated Statements of Income (Detail)	6 Months Ended
	Jun. 30, 2024 USD ($)
Other income (expense):
Discontinued operations, net	$ 1,534,479
AxoBio [Member]
Operating expenses:
Selling and marketing	100,000
Research and development	89,972
General and administrative	470,686
Depreciation and amortization	636,449
Total operating expenses	1,297,107
Loss from operations	(1,297,107)
Other income (expense):
Amortization of debt discount	(4,242)
Total other (expense) income	(111,261)
Loss before income taxes	(1,408,368)
Income tax benefit, deferred	156,092
Discontinued operations, net	$ (1,252,276)
Discontinued Operation, Gain (Loss) on Disposal, Statement of Income or Comprehensive Income [Extensible Enumeration]	Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Related Party [Member] | AxoBio [Member]
Other income (expense):
Interest expense	$ (89,448)
Nonrelated Party [Member] | AxoBio [Member]
Other income (expense):
Interest expense	$ (17,571)